OpenAlex
PricingAboutJobs
Log inGet started
Work

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

HTML

Year: 2003
Type: article
Study design: Clinical Trial
Source: Nicotine & Tobacco Research
DOI: 10.1080/14622200310001615295
Authors: Michael Murphy, Elaine Johnstone, Siân-Elin Griffiths, Robert Walton, Sean David, Raymond Niaura, George Papandonatos, William Shadel, Gary Burkholder, Dana Britt, Amy Day, Jeffrey Stumpff, Kent Hutchison
Institutions: Brown University, University of Colorado Boulder
Language: English

Topic: Smoking Behavior and Cessation
Subfield: Public Health, Environmental and Occupational Health
Field: Medicine
Domain: Health Sciences
Keywords: bupropion, dopamine D2 receptor, nicotine withdrawal, nicotine craving, genetic polymorphism, smoking cessation, pharmacogenetics, irritability, anxiety
SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Cancer Institute
Awards: G1041387446, Psychobiological /Genetic Determinants-Smoking Cessation, Nicotine Dependence: Phenotype, Endophenotype & Contexts, MATCHING ANTIDEPRESSANT TREATMENT FOR SMOKING CESSATION
OpenAlex ID: W2141151785
FWCI: 7.347
Cites: 49
Cited by: 65
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security